Ginkgo Bioworks Holdings Inc (NYSE:DNA)
| 1.36 Delayed Data As of Dec 08 |  +0.03 / +2.26%Today’s Change | 1.12 Today|||52-Week Range 2.55 | -19.53% Year-to-Date |
Latest DNA News | Press Releases
| If You Invested $1,000 in Ginkgo Bioworks in 2021, This Is How Much You Would Have Today Dec 01 / MotleyFool.com - Paid Partner Content | Looking for Growth? 2 Top Stocks to Buy Hand Over Fist Dec 01 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.33 |
| Today’s open | 1.31 |
| Day’s range | 1.28 - 1.37 |
| Volume | 17,912,783 |
| Average volume (3 months) | 19,729,848 |
| Market cap | -- |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -10.38% |
| Earnings growth (this year) | +73.18% |
| Earnings growth (next 5 years) | +31.67% |
| Revenue growth (last year) | +52.21% |
| P/E ratio | NM |
| Price/Sales | 5.94 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 25, 2024 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $477.7M |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -440.63% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters --, -- |
Forecasts
